495 related articles for article (PubMed ID: 30739589)
1. Genomic Reorganization of Lamin-Associated Domains in Cardiac Myocytes Is Associated With Differential Gene Expression and DNA Methylation in Human Dilated Cardiomyopathy.
Cheedipudi SM; Matkovich SJ; Coarfa C; Hu X; Robertson MJ; Sweet M; Taylor M; Mestroni L; Cleveland J; Willerson JT; Gurha P; Marian AJ
Circ Res; 2019 Apr; 124(8):1198-1213. PubMed ID: 30739589
[TBL] [Abstract][Full Text] [Related]
2. DNA Damage Response/TP53 Pathway Is Activated and Contributes to the Pathogenesis of Dilated Cardiomyopathy Associated With LMNA (Lamin A/C) Mutations.
Chen SN; Lombardi R; Karmouch J; Tsai JY; Czernuszewicz G; Taylor MRG; Mestroni L; Coarfa C; Gurha P; Marian AJ
Circ Res; 2019 Mar; 124(6):856-873. PubMed ID: 30696354
[TBL] [Abstract][Full Text] [Related]
3. DNA methylation analysis reveals epimutation hotspots in patients with dilated cardiomyopathy-associated laminopathies.
Morival JLP; Widyastuti HP; Nguyen CHH; Zaragoza MV; Downing TL
Clin Epigenetics; 2021 Jul; 13(1):139. PubMed ID: 34246298
[TBL] [Abstract][Full Text] [Related]
4. Integrated analysis reveals the alterations that LMNA interacts with euchromatin in LMNA mutation-associated dilated cardiomyopathy.
Zhang X; Shao X; Zhang R; Zhu R; Feng R
Clin Epigenetics; 2021 Jan; 13(1):3. PubMed ID: 33407844
[TBL] [Abstract][Full Text] [Related]
5. The LMNA mutation p.Arg321Ter associated with dilated cardiomyopathy leads to reduced expression and a skewed ratio of lamin A and lamin C proteins.
Al-Saaidi R; Rasmussen TB; Palmfeldt J; Nissen PH; Beqqali A; Hansen J; Pinto YM; Boesen T; Mogensen J; Bross P
Exp Cell Res; 2013 Nov; 319(19):3010-9. PubMed ID: 24001739
[TBL] [Abstract][Full Text] [Related]
6. TEAD1 trapping by the Q353R-Lamin A/C causes dilated cardiomyopathy.
Yamada S; Ko T; Ito M; Sassa T; Nomura S; Okuma H; Sato M; Imasaki T; Kikkawa S; Zhang B; Yamada T; Seki Y; Fujita K; Katoh M; Kubota M; Hatsuse S; Katagiri M; Hayashi H; Hamano M; Takeda N; Morita H; Takada S; Toyoda M; Uchiyama M; Ikeuchi M; Toyooka K; Umezawa A; Yamanishi Y; Nitta R; Aburatani H; Komuro I
Sci Adv; 2023 Apr; 9(15):eade7047. PubMed ID: 37058558
[TBL] [Abstract][Full Text] [Related]
7. Systematic in vivo candidate evaluation uncovers therapeutic targets for LMNA dilated cardiomyopathy and risk of Lamin A toxicity.
Tan CY; Chan PS; Tan H; Tan SW; Lee CJM; Wang JW; Ye S; Werner H; Loh YJ; Lee YL; Ackers-Johnson M; Foo RSY; Jiang J
J Transl Med; 2023 Oct; 21(1):690. PubMed ID: 37840136
[TBL] [Abstract][Full Text] [Related]
8. Lamin A/C haploinsufficiency causes dilated cardiomyopathy and apoptosis-triggered cardiac conduction system disease.
Wolf CM; Wang L; Alcalai R; Pizard A; Burgon PG; Ahmad F; Sherwood M; Branco DM; Wakimoto H; Fishman GI; See V; Stewart CL; Conner DA; Berul CI; Seidman CE; Seidman JG
J Mol Cell Cardiol; 2008 Feb; 44(2):293-303. PubMed ID: 18182166
[TBL] [Abstract][Full Text] [Related]
9. Clinical and functional characterization of a novel mutation in lamin a/c gene in a multigenerational family with arrhythmogenic cardiac laminopathy.
Forleo C; Carmosino M; Resta N; Rampazzo A; Valecce R; Sorrentino S; Iacoviello M; Pisani F; Procino G; Gerbino A; Scardapane A; Simone C; Calore M; Torretta S; Svelto M; Favale S
PLoS One; 2015; 10(4):e0121723. PubMed ID: 25837155
[TBL] [Abstract][Full Text] [Related]
10. Heterozygous LmnadelK32 mice develop dilated cardiomyopathy through a combined pathomechanism of haploinsufficiency and peptide toxicity.
Cattin ME; Bertrand AT; Schlossarek S; Le Bihan MC; Skov Jensen S; Neuber C; Crocini C; Maron S; Lainé J; Mougenot N; Varnous S; Fromes Y; Hansen A; Eschenhagen T; Decostre V; Carrier L; Bonne G
Hum Mol Genet; 2013 Aug; 22(15):3152-64. PubMed ID: 23575224
[TBL] [Abstract][Full Text] [Related]
11. Lamin A/C mutations in dilated cardiomyopathy.
Tesson F; Saj M; Uvaize MM; Nicolas H; Płoski R; Bilińska Z
Cardiol J; 2014; 21(4):331-42. PubMed ID: 24846508
[TBL] [Abstract][Full Text] [Related]
12. Defects in nuclear structure and function promote dilated cardiomyopathy in lamin A/C-deficient mice.
Nikolova V; Leimena C; McMahon AC; Tan JC; Chandar S; Jogia D; Kesteven SH; Michalicek J; Otway R; Verheyen F; Rainer S; Stewart CL; Martin D; Feneley MP; Fatkin D
J Clin Invest; 2004 Feb; 113(3):357-69. PubMed ID: 14755333
[TBL] [Abstract][Full Text] [Related]
13. Distinct features of lamin A-interacting chromatin domains mapped by ChIP-sequencing from sonicated or micrococcal nuclease-digested chromatin.
Lund EG; Duband-Goulet I; Oldenburg A; Buendia B; Collas P
Nucleus; 2015; 6(1):30-9. PubMed ID: 25602132
[TBL] [Abstract][Full Text] [Related]
14. Nuclear accumulation of androgen receptor in gender difference of dilated cardiomyopathy due to lamin A/C mutations.
Arimura T; Onoue K; Takahashi-Tanaka Y; Ishikawa T; Kuwahara M; Setou M; Shigenobu S; Yamaguchi K; Bertrand AT; Machida N; Takayama K; Fukusato M; Tanaka R; Somekawa S; Nakano T; Yamane Y; Kuba K; Imai Y; Saito Y; Bonne G; Kimura A
Cardiovasc Res; 2013 Aug; 99(3):382-94. PubMed ID: 23631840
[TBL] [Abstract][Full Text] [Related]
15. Pathogenic LMNA variants disrupt cardiac lamina-chromatin interactions and de-repress alternative fate genes.
Shah PP; Lv W; Rhoades JH; Poleshko A; Abbey D; Caporizzo MA; Linares-Saldana R; Heffler JG; Sayed N; Thomas D; Wang Q; Stanton LJ; Bedi K; Morley MP; Cappola TP; Owens AT; Margulies KB; Frank DB; Wu JC; Rader DJ; Yang W; Prosser BL; Musunuru K; Jain R
Cell Stem Cell; 2021 May; 28(5):938-954.e9. PubMed ID: 33529599
[TBL] [Abstract][Full Text] [Related]
16. Lamin A/C Ablation Restricted to Vascular Smooth Muscle Cells, Cardiomyocytes, and Cardiac Fibroblasts Causes Cardiac and Vascular Dysfunction.
Del Monte-Monge A; Ruiz-Polo de Lara Í; Gonzalo P; Espinós-Estévez C; González-Amor M; de la Fuente-Pérez M; Andrés-Manzano MJ; Fanjul V; Gimeno JR; Barriales-Villa R; Dorado B; Andrés V
Int J Mol Sci; 2023 Jul; 24(13):. PubMed ID: 37446344
[TBL] [Abstract][Full Text] [Related]
17. Quantitative expression of the mutated lamin A/C gene in patients with cardiolaminopathy.
Narula N; Favalli V; Tarantino P; Grasso M; Pilotto A; Bellazzi R; Serio A; Gambarin FI; Charron P; Meder B; Pinto Y; Elliott PM; Mogensen J; Bolognesi M; Bollati M; Arbustini E
J Am Coll Cardiol; 2012 Nov; 60(19):1916-20. PubMed ID: 23062543
[TBL] [Abstract][Full Text] [Related]
18. Genetic and ultrastructural studies in dilated cardiomyopathy patients: a large deletion in the lamin A/C gene is associated with cardiomyocyte nuclear envelope disruption.
Gupta P; Bilinska ZT; Sylvius N; Boudreau E; Veinot JP; Labib S; Bolongo PM; Hamza A; Jackson T; Ploski R; Walski M; Grzybowski J; Walczak E; Religa G; Fidzianska A; Tesson F
Basic Res Cardiol; 2010 May; 105(3):365-77. PubMed ID: 20127487
[TBL] [Abstract][Full Text] [Related]
19. Identification of Target Genes and Transcription Factors in Mice with LMNA-Related Dilated Cardiomyopathy by Integrated Bioinformatic Analyses.
Zhou H; Tan L; Lu T; Xu K; Li C; Liu Z; Peng H; Shi R; Zhang G
Med Sci Monit; 2020 Jun; 26():e924576. PubMed ID: 32581210
[TBL] [Abstract][Full Text] [Related]
20. DNA double-stranded breaks, a hallmark of aging, defined at the nucleotide resolution, are increased and associated with transcription in the cardiac myocytes in LMNA-cardiomyopathy.
Cathcart B; Cheedipudi SM; Rouhi L; Zhao Z; Gurha P; Marian AJ
Cardiovasc Res; 2024 Apr; ():. PubMed ID: 38577741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
